LIFECORE BIOMEDICAL, INC. \DE\ Quarterly Operating Income (Loss) in USD from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Lifecore Biomedical, Inc. \De\ quarterly/annual Operating Income (Loss) history and growth rate from Q3 2010 to Q3 2024.
  • Lifecore Biomedical, Inc. \De\ Operating Income (Loss) for the quarter ending August 25, 2024 was -$11.6M, a 34.5% decline year-over-year.
  • Lifecore Biomedical, Inc. \De\ Operating Income (Loss) for the twelve months ending August 25, 2024 was -$11.8M, a 56.5% increase year-over-year.
  • Lifecore Biomedical, Inc. \De\ annual Operating Income (Loss) for 2023 was -$8.84M, a 59.4% increase from 2022.
  • Lifecore Biomedical, Inc. \De\ annual Operating Income (Loss) for 2022 was -$21.8M, a 84.9% decline from 2021.
  • Lifecore Biomedical, Inc. \De\ annual Operating Income (Loss) for 2021 was -$11.8M, a 33.6% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$11.8M -$11.6M -$2.97M -34.5% May 27, 2024 Aug 25, 2024 10-Q 2024-10-04
Q2 2024 -$8.84M $2.15M +$8.79M Feb 26, 2024 May 26, 2024 10-K 2024-08-26
Q1 2024 -$17.6M -$895K +$5.64M +86.3% Nov 27, 2023 Feb 25, 2024 10-Q 2024-08-09
Q4 2023 -$23.3M -$1.48M +$3.87M +72.3% Aug 28, 2023 Nov 26, 2023 10-Q 2024-08-09
Q3 2023 -$27.1M -$8.61M -$5.34M -163% May 29, 2023 Aug 27, 2023 10-Q 2024-10-04
Q2 2023 -$21.8M -$6.64M -$5.02M -310% Feb 27, 2023 May 28, 2023 10-K 2024-08-26
Q1 2023 -$16.8M -$6.53M +$3.11M +32.2% Nov 28, 2022 Feb 26, 2023 10-Q 2024-08-09
Q4 2022 -$19.9M -$5.35M -$9.04M -245% Aug 29, 2022 Nov 27, 2022 10-Q 2024-08-09
Q3 2022 -$10.8M -$3.27M +$949K +22.5% May 30, 2022 Aug 28, 2022 10-Q 2024-08-09
Q2 2022 -$11.8M -$1.62M -$1.95M -588% Feb 28, 2022 May 29, 2022 10-K 2024-08-26
Q1 2022 -$9.84M -$9.64M -$9.71M -13303% Nov 29, 2021 Feb 27, 2022 10-K 2024-03-20
Q4 2021 -$128K $3.69M +$2.32M +169% Aug 30, 2021 Nov 28, 2021 10-K 2024-03-20
Q3 2021 -$2.44M -$4.22M +$6.38M +60.2% May 31, 2021 Aug 29, 2021 10-K 2024-03-20
Q2 2021 -$8.82M $332K +$781K Mar 1, 2021 May 30, 2021 10-K 2024-03-20
Q1 2021 -$9.6M $73K +$15.1M Nov 30, 2020 Feb 28, 2021 10-K 2024-03-20
Q4 2020 -$24.7M $1.37M +$7.41M Aug 31, 2020 Nov 29, 2020 10-K 2024-03-20
Q3 2020 -$32.1M -$10.6M -$6.22M -142% Jun 1, 2020 Aug 30, 2020 10-K 2024-03-20
Q2 2020 -$25.9M -$449K -$2.93M -118% Feb 24, 2020 May 31, 2020 10-K/A 2023-03-16
Q1 2020 -$22.9M -$15M -$18.3M -563% Nov 25, 2019 Feb 23, 2020 10-Q 2021-04-08
Q4 2019 -$4.69M -$6.04M -$6.05M -60460% Aug 26, 2019 Nov 24, 2019 10-Q 2021-01-07
Q3 2019 $1.35M -$4.38M -$4.12M -1604% May 27, 2019 Aug 25, 2019 10-Q 2020-10-07
Q2 2019 $5.48M $2.48M -$5.59M -69.3% Feb 25, 2019 May 26, 2019 10-K 2021-07-29
Q1 2019 $11.1M $3.24M -$243K -6.97% Nov 26, 2018 Feb 24, 2019 10-Q 2020-04-03
Q4 2018 $11.3M $10K +$705K Aug 27, 2018 Nov 25, 2018 10-Q 2020-01-02
Q3 2018 $10.6M -$257K -$2.98M -109% May 28, 2018 Aug 26, 2018 10-Q 2019-10-03
Q2 2018 $13.6M $8.07M +$6.47M +403% Feb 26, 2018 May 27, 2018 10-K 2020-08-14
Q1 2018 $7.12M $3.49M -$844K -19.5% Nov 27, 2017 Feb 25, 2018 10-Q 2019-04-04
Q4 2017 $7.96M -$695K -$3.96M -121% Aug 28, 2017 Nov 26, 2017 10-Q 2019-01-07
Q3 2017 $11.9M $2.73M -$2.75M -50.2% May 29, 2017 Aug 27, 2017 10-Q 2018-10-05
Q2 2017 $14.7M $1.61M -$4.65M -74.3% Feb 27, 2017 May 28, 2017 10-K 2019-08-01
Q1 2017 $19.3M $4.33M +$38M Nov 28, 2016 Feb 26, 2017 10-Q 2018-04-05
Q4 2016 -$18.6M $3.26M +$457K +16.3% Aug 29, 2016 Nov 27, 2016 10-Q 2018-01-05
Q3 2016 -$19.1M $5.47M +$1.53M +38.9% May 30, 2016 Aug 28, 2016 10-Q 2017-09-28
Q2 2016 -$20.6M $6.25M +$48K +0.77% Feb 29, 2016 May 29, 2016 10-K 2018-08-09
Q1 2016 -$20.7M -$33.6M -$38.5M -796% Nov 30, 2015 Feb 28, 2016 10-Q 2017-04-07
Q4 2015 $17.8M $2.81M -$1.09M -27.9% Aug 31, 2015 Nov 29, 2015 10-Q 2017-01-05
Q3 2015 $18.9M $3.94M +$403K +11.4% Jun 1, 2015 Aug 30, 2015 10-Q 2016-09-29
Q2 2015 $18.5M $6.2M +$897K +16.9% Mar 2, 2015 May 31, 2015 10-K/A 2018-03-15
Q1 2015 $17.6M $4.83M -$4.9M -50.3% Dec 1, 2014 Mar 1, 2015 10-Q 2016-03-30
Q4 2014 $22.5M $3.89M +$716K +22.5% Sep 1, 2014 Nov 30, 2014 10-Q 2016-01-07
Q3 2014 $21.7M $3.53M +$1.56M +78.8% Jun 2, 2014 Aug 31, 2014 10-Q 2015-10-01
Q2 2014 $20.2M $5.31M +$1.19M +29% Feb 24, 2014 May 25, 2014 10-K 2016-08-01
Q1 2014 $19M $9.73M +$3.07M +46.1% Nov 25, 2013 Feb 23, 2014 10-Q 2015-04-02
Q4 2013 $15.9M $3.18M -$7.92M -71.4% Aug 26, 2013 Nov 24, 2013 10-Q 2015-01-09
Q3 2013 $23.8M $1.98M -$1.03M -34.2% May 27, 2013 Aug 25, 2013 10-Q 2014-10-08
Q2 2013 $24.9M $4.11M +$653K +18.9% Feb 25, 2013 May 26, 2013 10-K 2015-07-31
Q1 2013 $24.2M $6.66M +$2.62M +65% Nov 26, 2012 Feb 24, 2013 10-Q 2014-03-28
Q4 2012 $21.6M $11.1M +$6.88M +164% Aug 27, 2012 Nov 25, 2012 10-Q 2014-01-03
Q3 2012 $14.7M $3M +$130K +4.53% May 28, 2012 Aug 26, 2012 10-Q 2013-09-26
Q2 2012 $14.6M $3.46M +$6.63M Feb 27, 2012 May 27, 2012 10-K 2014-08-01
Q1 2012 $7.94M $4.04M +$290K +7.74% Nov 28, 2011 Feb 26, 2012 10-Q 2013-04-04
Q4 2011 $7.65M $4.21M +$681K +19.3% Aug 29, 2011 Nov 27, 2011 10-Q 2013-01-04
Q3 2011 $6.97M $2.87M -$1.06M -27% May 30, 2011 Aug 28, 2011 10-Q/A 2013-01-02
Q2 2011 $8.03M -$3.17M Feb 28, 2011 May 29, 2011 10-K 2013-08-07
Q1 2011 $3.75M Nov 29, 2010 Feb 27, 2011 10-Q 2012-03-28
Q4 2010 $3.53M Aug 30, 2010 Nov 28, 2010 10-Q 2012-01-05
Q3 2010 $3.93M Jun 1, 2010 Aug 29, 2010 10-Q 2011-10-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.